The effect of intravesical thio-tepa on normal and tumor urothelium
- PMID: 413937
- DOI: 10.1016/s0022-5347(17)57383-8
The effect of intravesical thio-tepa on normal and tumor urothelium
Abstract
Intravesical thio-tepa instillations for 55 patients with superficial transitional cell carcinoma were evaluated prospectively in the treatment of residual disease (therapeutic) and the prevention of recurrence (prophylactic). The over-all response rate to therapeutic thio-tepa was 56 per cent, with toxicity observed in 26 per cent of the cases. Patients with microscopic residual tumor showed better response and less toxicity than those with gross residual tumor. Prophylactic thio-tepa had no effect in lowering recurrence rates. Examination of pre-treatment and post-treatment biopsies showed no worsening of atypia and no correlation between improvement in atypia and gross tumor response. A charcteristic post-treatment thio-tepa effect was observed in non-tumorous urothelium but not in tumor biopsies. The differentiation of such thio-tepa effect cells from pre-malignant atypical cells is discussed.
Similar articles
-
Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.Invest Urol. 1979 May;16(6):486-8. Invest Urol. 1979. PMID: 109416
-
A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.J Urol. 1979 Jul;122(1):27-9. doi: 10.1016/s0022-5347(17)56236-9. J Urol. 1979. PMID: 110947
-
Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.Isr J Med Sci. 1980 Sep-Oct;16(9-10):714-6. Isr J Med Sci. 1980. PMID: 6776072
-
Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.Prog Clin Biol Res. 1989;310:215-36. Prog Clin Biol Res. 1989. PMID: 2505268 Review.
-
Rationale for intensive intravesical chemotherapy for superficial bladder cancer.J Urol. 1980 Apr;123(4):461-6. doi: 10.1016/s0022-5347(17)55976-5. J Urol. 1980. PMID: 6767860 Review. No abstract available.
Cited by
-
Superficial bladder cancer: state of the art.Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931. Cancer Chemother Pharmacol. 1994. PMID: 7994780 Review. No abstract available.
-
Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.Cancer Chemother Pharmacol. 1983;11 Suppl:S79-82. doi: 10.1007/BF00256725. Cancer Chemother Pharmacol. 1983. PMID: 6416701 Clinical Trial.
-
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.Cancer Chemother Pharmacol. 1983;11 Suppl:S16-21. doi: 10.1007/BF00256711. Cancer Chemother Pharmacol. 1983. PMID: 6416698 Clinical Trial.
-
In vitro chemosensitivity of J-82 human bladder cancer cells.Urol Res. 1986;14(3):141-4. doi: 10.1007/BF00255833. Urol Res. 1986. PMID: 3750594
-
Intravesical chemotherapy in the United States. An overview.Cancer Chemother Pharmacol. 1983;11 Suppl:S5-8. doi: 10.1007/BF00256708. Cancer Chemother Pharmacol. 1983. PMID: 6196136 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources